Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ABBV-291 by AbbVie for Mantle Cell Lymphoma: Likelihood of Approval
ABBV-291 is under clinical development by AbbVie and currently in Phase I for Mantle Cell Lymphoma. According to GlobalData, Phase...